Applied Statistics

Immunology: Roche AG

Total Score People Score Events Score
15 15 11
Date Event Presentation Speakers
November 7, 2010 Frontiers of Immunology in Health and Diseases Frontiers of Immunology in Health and Diseases Jinzhi Chen
October 13, 2009 2009 PDA/EMEA Joint Conference: Ensuring Patient Safety through Supply Chain Control and GMP S4: Good distribution practice (GDP) Michael P Dillon
June 3, 2009 Inaugural Drug Induced Liver Injury In vivo and in vitro prediction of DILI using genomics Adrian Roth
February 9, 2009 Immunogenicity for Biologics 2009 A concerted and staggered implementation of different assays and methods for antibody screening and characterisation Julia Schleypen
January 28, 2009 Clinical Trials for Special Populations Biomarkers in oncology clinical trials Chee Gee See
Successful alternatives: A case study contrasting two different, but successful, strategies generating sufficient data from an elderly population to permit licensure of novel antiviral treatments for influenza Penelope Ward
December 1, 2008 European Antibody Congress 2008 GA101, a novel glycoengineered type II CD20 antibody with outstanding anti-tumor efficacy and superior B cell depletion Christian Klein
October 28, 2008 Bridging Pharma and IT Kinase Data Mart: Browsing and Shopping for Kinase Data Hans Bitter, Rama K. Kondru
September 17, 2008 BACULOVIRUS TECHNOLOGY Application of Baculovirus in GPCR and Ion Channel Protein Expression in Mammalian Cells Simon Lee
August 18, 2008 Systems Integration in Biodefense REIMBURSEMENT AND REGULATORY ISSUES Kathleen Claessens
March 25, 2008 Molecular Diagnostics Chairperson’s Remarks Linda McAllister
Personalized Health Care at Roche: Development of Tests for Response Prediction in Oncology Gerd Maass
Organizational, Strategic and Technical Considerations for Creating Clinically Differentiated Medicines and Companion Diagnostics: Successes vs. Failures, What Did We Learn? Tim M. Jaeger
September 26, 2007 EuroBio2007 (Sep 26th - 28th) BIOTECH ECONOMY AND BUSINESS DEVELOPMENT (09:00 - 14:00) Herve Henaff
BIOTECH ECONOMY AND BUSINESS DEVELOPMENT: Questioning the efficiency of Drugs regulations: A critical look. (11:00 - 13:00) Herve Henaff
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.